marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
.
her twins' cases were published, along with that of a third baby boy, in april in the
.
.
.
. however, bentley also warned that these treatments can be hazardous as they may cause bleeding which becomes more likely as the amount of svd increases.